Human Immunodeficiency Virus (HIV) viral load suppression status and associated factors among pregnant women receiving Highly Active Antiretroviral Therapy (HAART) in Ethiopia

Table 1 Clinical characteristics of pregnant women living with HIV, 2023

Variable	Category	Frequency	Percent (%)
ART Regimen	First Line	7468	96.19
	Second Line	171	2.20
	Third Line	125	1.61
Timing of VL testing	1st tested after 3 months during ANC visit*	2550	33.14
	2nd VL at 6 Month**	1352	17.41
	At 34–36 weeks ofgestation***	3839	49.45
	At the first ANC visit****	23	0.30
Adherence	Good	7504	96.65
	Poor	260	3.35

*Those pregnant women tested for HIV and know their results and initiated ART tested for HIV viral load after three months of initiating the ART
**HIV viral load test performed after six month of ART initiation during their ANC follow up. This is for pregnant women knew their HIV status during their ANC follow up and started ART
***Pregnant women knew their HIV status and started ART before ANC follow up. Therefore, during at 34–36 weeks of gestation, HIV viral load should be tested
****Pregnant women knew their HIV status and started ART before ANC follow up. Therefore, during their first ANC visit, HIV viral load should be tested

ISSN: 1743-422X